Abbvie Limited

Lobbying Organisation Abbvie Limited

Date published 21 Sep, 2018

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 May, 2018 to 31 Aug, 2018

Specific Details To highlight delays in access to an innovative new medicine for Chronic Lymphocytic Leukaemia for patients in Ireland that is available in other European countries

Intended results To gain timely access for Irish Patients to new innovative cancer treatments that are available to patients in Europe

Name of person primarily responsible for lobbying on this activity Todd Manning

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Event / Reception (1)

Briefed the TD on the issue of delayed access for a new cancer medicine at the Abbvie Week of Possibilities school volunteering event

Email (1)

Email to update the TD on outcome of reimbursement process

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Colm Brophy TD (Dáil Éireann, the Oireachtas)